Haleon (FRA:H6D) Ending Cash Position: €932 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:H6D Haleon PLC FRA:H6D
73 GF Score
Price €8.50
GF Value €8.69
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Haleon Ending Cash Position?

Haleon FRA:H6D -0.58% 73 Ending Cash Position is €932 Mil as of Jun. 2026. GuruFocus rates FRA:H6D with a GF Score™ of 73/100 and a GF Value™ of €8.69 (Fairly Valued). The stock has 2 warning signs investors should review.

Haleon's Ending Cash Position for the quarter that ended in Jun. 2026 was €932 Mil.

Haleon's quarterly Ending Cash Position increased from Jun. 2025 (€736 Mil) to Dec. 2025 (€1,490 Mil) but then declined from Dec. 2025 (€1,490 Mil) to Jun. 2026 (€932 Mil).

Haleon's annual Ending Cash Position increased from Dec. 2023 (€1,154 Mil) to Dec. 2024 (€2,665 Mil) but then declined from Dec. 2024 (€2,665 Mil) to Dec. 2025 (€1,490 Mil).

Haleon Ending Cash Position Related Terms

Haleon Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Haleon's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Haleon Ending Cash Position Chart

Haleon Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial 477.81 702.54 1,153.80 2,664.58 1,489.64

Haleon Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 581.51 2,070.58 736.42 1,489.64 931.65
FRA:H6D
73GF Score
Haleon PLC FRA:H6D
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Haleon Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Haleon's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=2523.13+-1033.489
=1,490

Haleon's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=1508.005+-576.352
=932

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of €932 Mil mean?
Haleon (FRA:H6D) has a Ending Cash Position of €932 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Haleon and its competitors.
Is Haleon's Ending Cash Position too high?
Haleon's current Ending Cash Position is €932 Mil. Overall, Haleon has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Haleon's Ending Cash Position compare to ZTS and UTHR?
Haleon's Ending Cash Position of €932 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Drug Manufacturers company?
A good Ending Cash Position depends on the Drug Manufacturers industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Haleon and its competitors. Haleon's current Ending Cash Position is €932 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haleon stock overvalued right now?
Based on GuruFocus' analysis, Haleon (FRA:H6D) is currently considered Fairly Valued. The stock's GF Value™ is €8.69, compared to a current price of €8.50 — trading 2.2% below its estimated fair value. The current Ending Cash Position is €932 Mil. Haleon's overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Haleon (FRA:H6D), the current Ending Cash Position is €932 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Haleon (FRA:H6D) Overvalued in 2026?

Based on GuruFocus' analysis, Haleon stock appears to be undervalued. The current stock price of €8.50 is trading 2.2% below its estimated GF Value™ of €8.69. GuruFocus considers Haleon to be Fairly Valued.

Key valuation signals for FRA:H6D:

  • Ending Cash Position: €932 Mil
  • GF Value™: €8.69 vs. price of €8.50 (2.2% below fair value)
  • GF Score™: 73/100 with 2 warning signs

No single metric tells the full story. See the FRA:H6D stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Haleon Business Description

Address The Heights, Building 5, First Floor, Weybridge, Surrey, GBR, KT13 0NY
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
73GF Score

Get the complete analysis for FRA:H6D

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.50
Price
€8.69
GF Value